MedPath
NMPA Approval

Reserpine Injection

国药准字H22020406

December 18, 2023

Drug Information

利血平注射液

注射剂

1ml:2.5mg

化学药品

December 18, 2023

Company Information

Applicant Company

长春经济技术开发区海口路572号

Manufacturing Company

长春经济技术开发区海口路572号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利血平注射液 - NMPA 批准文号 | MedPath